In 2023, the standardized rate for female tuberculosis deaths per hundred women in Canada stood at a certain level, experiencing a flat forecast from 2024 to 2027 at 100.0. A sharp decline to 0.0 is projected in 2028, signaling a drastic change in mortality rates. With no significant variation until 2028, there is no percentage change from 2024 to 2027, indicating a stable outlook.
The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 suggests a potentially rapid rate of decline in tuberculosis mortality starting in 2028.
Future trends to watch for include advancements in healthcare policies, treatments, and public health interventions to understand if such a dramatic decrease in mortality is feasible and sustainable beyond 2028. Monitoring innovations in tuberculosis treatment and vaccine development, along with changing social determinants of health, remains crucial for forecasting future trends.
